Navigation Links
Giving Patients a Lift
Date:2/20/2008

Travel Grant Program For Mesothelioma Patients

CHICAGO, Feb. 20 /PRNewswire/ -- The Mesothelioma Applied Research Foundation (Meso Foundation) has established the Mary and Bob Cosentino Travel Grant Program to help newly-diagnosed patients consult with an expert on this very grave asbestos-related cancer.

Mesothelioma is a malignant tumor that aggressively and painfully invades the lining of the lungs, heart or stomach until it destroys the vital organs. Research to understand mesothelioma and to develop effective treatments has lagged far behind other cancers. As a result, most available treatments are experimental and available only at one of the handful of medical centers that specialize in mesothelioma.

"Mesothelioma patients and their families typically face huge financial losses," explained Chris Hahn, Executive Director of The Meso Foundation. "They lose employment income due to disability and the need for the caregiver to stay at home with the patient. The available treatments often are not covered by medical insurance, and even accessing those treatments are expensive because many patients do not live in close proximity to centers with mesothelioma expertise, and travel and lodging can be costly."

Mary Cosentino served on the Board of Directors of the Meso Foundation. Mary passed away last month last month, on January 26, from peritoneal mesothelioma, more than five years after she was diagnosed. Statistically, the disease's prognosis is only about a year, but Mary sought and benefited from several clinical trials and experimental protocols offered by specialists across the country. She and her husband Bob have been long time supporters of The Meso Foundation.

"There are some patients unable to consult with experts at major mesothelioma centers because they cannot afford travel expenses," said Bob Cosentino. "Those concerns are what prompted us to contribute to the Travel Grant Program established by The
'/>"/>

SOURCE Meso Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Informational handout key to giving parents a better understanding of CT radiation risks
2. Giving CPR Kits to Kids Nudges Parents to Learn
3. Mothers milk a gift that keeps on giving
4. Giving emergency nurses aromatherapy massages with music dramatically reduced stress levels
5. Elder Caregiving Site ShirleyBOARD.com Wins WebAward for Outstanding Online Community
6. Giving emergency nurses aromatherapy massages with music dramatically reduced stress levels
7. NEWSWEEK: Cover: Giving Globally: How to Heal the World
8. Novartis Vaccines Launches National Gift-Giving Program to Help Protect Loved Ones by Reserving an Influenza Vaccination
9. AUDIO from Medialink and AARP: Giving Flu Prevention a Shot in the Arm
10. Giving Back to the Community Golden Corral Style
11. USC study examines effects of caregiving
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3New Research Shows a Vitamin/Nutriceutical Formulation Improves Memory and Cognitive Performance in Community-Dwelling Adults 2TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting 2For Patients With Irritable Bowel Syndrome 28IBS 29 iPhone to the Rescue 47442 1For Patients With Irritable Bowel Syndrome 28IBS 29 iPhone to the Rescue 47442 2For Patients With Irritable Bowel Syndrome 28IBS 29 iPhone to the Rescue 47442 3Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 1Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 2Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 3Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 4Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 5Study shows gay couples want legal rights regardless of marriage 47439 1Study shows gay couples want legal rights regardless of marriage 47439 2